Gene p73

Deletions and expression in non-small-cell lung carcinoma cells

Viktor Chizhikov, I. B. Zborovskaya, A. G. Tatosyan, A. V. Gasparyan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We studied the relation between genetic anomalies in the p73 gene encoding a product structurally and functionally similar to the protein p53 and the pathogenesis of non-small-cell lung carcinoma (NSCLC; 83 patients). Loss of one of the p73 alleles was revealed in 44% (15/34) informative cases. Presence of deletions correlated with the features common for tumor development: metastatic affection of regional lymph nodes (p = 0.045), large tumor size (p = 0.037), advanced stage of the disease (p = 0.017). Allele expression of the gene p73 was studied basing on analysis of the polymorphic C/T site in the second exon. All ten studied samples of normal bronchogenic epithelium showed monoallelic expression of p73, contrary to the six NSCLC samples which preserved both of the p73 alleles and showed biallelic expression. Enhanced expression of p73 mRNA in tumor tissue compared with normal bronchogenic epithelium was found in 28 of 34 (82.4%) NSCLC patients. Expression of p73 in NSCLC cells showed correlation neither with deletions of one of the alleles, nor with any parameter reflecting clinical pathology. The results suggest that p73 is not a classical tumor suppressor gene in NSCLC. However, alterations of p73 expression are common for NSCLC. This may be important for our understanding of the NSCLC origin and development.

Original languageEnglish (US)
Pages (from-to)403-407
Number of pages5
JournalMolecular Biology
Volume34
Issue number3
DOIs
StatePublished - Jan 1 2000

Fingerprint

Gene Deletion
Non-Small Cell Lung Carcinoma
Alleles
Gene Expression
Epithelium
Neoplasms
Clinical Pathology
Tumor Suppressor Genes
Exons
Lymph Nodes
Messenger RNA
Genes
Proteins

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Structural Biology

Cite this

Gene p73 : Deletions and expression in non-small-cell lung carcinoma cells. / Chizhikov, Viktor; Zborovskaya, I. B.; Tatosyan, A. G.; Gasparyan, A. V.

In: Molecular Biology, Vol. 34, No. 3, 01.01.2000, p. 403-407.

Research output: Contribution to journalArticle

Chizhikov, Viktor ; Zborovskaya, I. B. ; Tatosyan, A. G. ; Gasparyan, A. V. / Gene p73 : Deletions and expression in non-small-cell lung carcinoma cells. In: Molecular Biology. 2000 ; Vol. 34, No. 3. pp. 403-407.
@article{7c5b1e3d2d3f424b960688e75633b7a9,
title = "Gene p73: Deletions and expression in non-small-cell lung carcinoma cells",
abstract = "We studied the relation between genetic anomalies in the p73 gene encoding a product structurally and functionally similar to the protein p53 and the pathogenesis of non-small-cell lung carcinoma (NSCLC; 83 patients). Loss of one of the p73 alleles was revealed in 44{\%} (15/34) informative cases. Presence of deletions correlated with the features common for tumor development: metastatic affection of regional lymph nodes (p = 0.045), large tumor size (p = 0.037), advanced stage of the disease (p = 0.017). Allele expression of the gene p73 was studied basing on analysis of the polymorphic C/T site in the second exon. All ten studied samples of normal bronchogenic epithelium showed monoallelic expression of p73, contrary to the six NSCLC samples which preserved both of the p73 alleles and showed biallelic expression. Enhanced expression of p73 mRNA in tumor tissue compared with normal bronchogenic epithelium was found in 28 of 34 (82.4{\%}) NSCLC patients. Expression of p73 in NSCLC cells showed correlation neither with deletions of one of the alleles, nor with any parameter reflecting clinical pathology. The results suggest that p73 is not a classical tumor suppressor gene in NSCLC. However, alterations of p73 expression are common for NSCLC. This may be important for our understanding of the NSCLC origin and development.",
author = "Viktor Chizhikov and Zborovskaya, {I. B.} and Tatosyan, {A. G.} and Gasparyan, {A. V.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1007/BF02759672",
language = "English (US)",
volume = "34",
pages = "403--407",
journal = "Molecular Biology",
issn = "0026-8933",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "3",

}

TY - JOUR

T1 - Gene p73

T2 - Deletions and expression in non-small-cell lung carcinoma cells

AU - Chizhikov, Viktor

AU - Zborovskaya, I. B.

AU - Tatosyan, A. G.

AU - Gasparyan, A. V.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - We studied the relation between genetic anomalies in the p73 gene encoding a product structurally and functionally similar to the protein p53 and the pathogenesis of non-small-cell lung carcinoma (NSCLC; 83 patients). Loss of one of the p73 alleles was revealed in 44% (15/34) informative cases. Presence of deletions correlated with the features common for tumor development: metastatic affection of regional lymph nodes (p = 0.045), large tumor size (p = 0.037), advanced stage of the disease (p = 0.017). Allele expression of the gene p73 was studied basing on analysis of the polymorphic C/T site in the second exon. All ten studied samples of normal bronchogenic epithelium showed monoallelic expression of p73, contrary to the six NSCLC samples which preserved both of the p73 alleles and showed biallelic expression. Enhanced expression of p73 mRNA in tumor tissue compared with normal bronchogenic epithelium was found in 28 of 34 (82.4%) NSCLC patients. Expression of p73 in NSCLC cells showed correlation neither with deletions of one of the alleles, nor with any parameter reflecting clinical pathology. The results suggest that p73 is not a classical tumor suppressor gene in NSCLC. However, alterations of p73 expression are common for NSCLC. This may be important for our understanding of the NSCLC origin and development.

AB - We studied the relation between genetic anomalies in the p73 gene encoding a product structurally and functionally similar to the protein p53 and the pathogenesis of non-small-cell lung carcinoma (NSCLC; 83 patients). Loss of one of the p73 alleles was revealed in 44% (15/34) informative cases. Presence of deletions correlated with the features common for tumor development: metastatic affection of regional lymph nodes (p = 0.045), large tumor size (p = 0.037), advanced stage of the disease (p = 0.017). Allele expression of the gene p73 was studied basing on analysis of the polymorphic C/T site in the second exon. All ten studied samples of normal bronchogenic epithelium showed monoallelic expression of p73, contrary to the six NSCLC samples which preserved both of the p73 alleles and showed biallelic expression. Enhanced expression of p73 mRNA in tumor tissue compared with normal bronchogenic epithelium was found in 28 of 34 (82.4%) NSCLC patients. Expression of p73 in NSCLC cells showed correlation neither with deletions of one of the alleles, nor with any parameter reflecting clinical pathology. The results suggest that p73 is not a classical tumor suppressor gene in NSCLC. However, alterations of p73 expression are common for NSCLC. This may be important for our understanding of the NSCLC origin and development.

UR - http://www.scopus.com/inward/record.url?scp=0034178687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034178687&partnerID=8YFLogxK

U2 - 10.1007/BF02759672

DO - 10.1007/BF02759672

M3 - Article

VL - 34

SP - 403

EP - 407

JO - Molecular Biology

JF - Molecular Biology

SN - 0026-8933

IS - 3

ER -